ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998

New Grants In Ovarian Cancer Ok’d In Concepts By DCBDC Advisors

March 27, 1992

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012